Circulating Smooth Muscle Progenitors and Atherosclerosis

Trends in Cardiovascular Medicine

Volumn 20, Issue 4, 2010, Pages 133-140

  Albiero, Mattia ^a   Menegazzo, Lisa ^a   Fadini, Gian Paolo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE STEM CELL; STEM CELL;

ARTERIOSCLEROSIS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; STEM CELLS;

EID: 79951543949     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.12.001     Document Type: Review

References (67)

1. Abe R., Donnelly S.C., Peng T., et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166:7556-7562.
2. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
3. Assmus B., Walter D.H., Lehmann R., et al. Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction. Eur Heart J 2006, 27:2989-2995.
4. Bentzon J.F., Falk E. Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: current perspective and methods of analysis. Vascul Pharmacol 2010, 52:11-20.
5. Bentzon J.F., Sondergaard C.S., Kassem M., Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007, 116:2053-2061.
6. Bentzon J.F., Weile C., Sondergaard C.S., et al. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:2696-2702.
7. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
8. Bucala R., Spiegel L.A., Chesney J., et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1:71-81.
9. Caplice N.M., Bunch T.J., Stalboerger P.G., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 2003, 100:4754-4759.
10. Daniel J.M., Bielenberg W., Stieger P., et al. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol 2010, 30:1890-1896.
11. Deb A., Skelding K.A., Wang S., et al. Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 2004, 110:2673-2677.
12. Díez M., Musri M.M., Ferrer E., et al. Endothelial progenitor cells undergo an endothelial to mesenchymal transition-like process mediated by TGF{beta}RI. Cardiovasc Res 2010, 88:502-511.
13. Fadini G.P., Agostini C., Sartore S., Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194:46-54.
14. Fadini G.P., Baesso I., Albiero M., et al. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008, 197:496-503.
15. Fadini G.P., Tjwa M. A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis 2010, 211:32-35.
16. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006, 47:C7-12.
17. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
18. Frid M.G., Moiseeva E.P., Stenmark K.R. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 1994, 75:669-681.
19. Fukuda D., Sata M., Tanaka K., Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 2005, 111:926-931.
20. Geng Y.J., Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002, 22:1370-1380.
21. Gittenberger-de Groot A.C., DeRuiter M.C., Bergwerff M., Poelmann R.E. Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 1999, 19:1589-1594.
22. Glass C.K., Witztum J.L. Atherosclerosis. the road ahead. Cell 2001, 104:503-516.
23. Han C.I., Campbell G.R., Campbell J.H. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001, 38:113-119.
24. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
25. Hao H., Gabbiani G., Bochaton-Piallat M.L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003, 23:1510-1520.
26. Hao H., Ropraz P., Verin V., et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 2002, 22:1093-1099.
27. Herzog E.L., Bucala R. Fibrocytes in health and disease. Exp Hematol 2010, 38:548-556.
28. Hoofnagle M.H., Thomas J.A., Wamhoff B.R., Owens G.K. Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol 2006, 26:2579-2581.
29. Hristov M., Fach C., Becker C., et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007, 192:413-420.
30. Hu Y., Davison F., Ludewig B., et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:1834-1839.
31. Hu Y., Mayr M., Metzler B., et al. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 2002, 91:e13-e20.
32. Hu Y., Zhang Z., Torsney E., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113:1258-1265.
33. Imamura H., Ohta T., Tsunetoshi K., et al. Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by transforming growth factor-beta1. Atherosclerosis 2010, 211:114-121.
34. Iwata H., Manabe I., Fujiu K., et al. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 2010, 122:2048-2057.
35. Keeley E.C., Mehrad B., Strieter R.M. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 2009, 101:613-618.
36. Kolodgie F.D., Narula J., Yuan C., et al. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?. J Am Coll Cardiol 2007, 49:2093-2101.
37. Kumar A.H., Metharom P., Schmeckpeper J., et al. Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J 2010, 24:81-92.
38. Lee R.T., Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997, 17:1859-1867.
39. Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 2005, 49:1063-1071.
40. Le Ricousse-Roussanne S., Barateau V., Contreres J.O., et al. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 2004, 62:176-184.
41. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995, 91:2844-2850.
42. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
43. Li J., Han X., Jiang J., et al. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol 2001, 158:1943-1947.
44. Metharom P., Kumar A.H., Weiss S., Caplice N.M. A specific subset of mouse bone marrow cells has smooth muscle cell differentiation capacity-brief report. Arterioscler Thromb Vasc Biol 2010, 30:533-535.
45. Metharom P., Liu C., Wang S., et al. Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo. Atherosclerosis 2008, 198:29-38.
46. Miano J.M., Kelly L.A., Artacho C.A., et al. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation 1998, 98:1219-1227.
47. Milei J., Parodi J.C., Alonso G.F., et al. Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved. Am Heart J 1998, 136:1096-1105.
48. Miyata T., Iizasa H., Sai Y., et al. Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J Cell Physiol 2005, 204:948-955.
49. Moonen J.R., Krenning G., Brinker M.G., et al. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc Res 2010, 86:506-515.
50. Nguyen T.Q., Chon H., Van Nieuwenhoven F.A., et al. Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?. Diabetologia 2006, 49:1039-1048.
51. Ross R., Glomset J.A. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976, 295:369-377.
52. Saiura A., Sata M., Hirata Y., et al. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001, 7:382-383.
53. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
54. Sata M., Tanaka K., Nagai R. Origin of smooth muscle progenitor cells: different conclusions from different models. Circulation 2003, 107:e106-e107. (author reply e106-7).
55. Schwartz S.M., Galis Z.S., Rosenfeld M.E., Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007, 27:705-713.
56. Shah P.K. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003, 41:15S-22S.
57. Shimizu K., Sugiyama S., Aikawa M., et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001, 7:738-741.
58. Simper D., Stalboerger P.G., Panetta C.J., et al. Smooth muscle progenitor cells in human blood. Circulation 2002, 106:1199-1204.
59. Sugiyama S., Kugiyama K., Nakamura S., et al. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis 2006, 187:351-362.
60. Tanaka K., Sata M., Natori T., et al. Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice. FASEB J 2008, 22:428-436.
61. Timmermans F., Plum J., Yöder M.C., et al. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009, 13:87-102.
62. Westerweel P.E., Hoefer I.E., Blankestijn P.J., et al. End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol 2007, 292:F1132-F1140.
63. Westerweel P.E., Van Velthoven C.T., Nguyen T.Q., et al. Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol 2010, 9:55.
64. Yamada T., Kondo T., Numaguchi Y., et al. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol 2007, 27:2363-2369.
65. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
66. Zengin E., Chalajour F., Gehling U.M., et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 2006, 133:1543-1551.
67. Zoll J., Fontaine V., Gourdy P., et al. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 2008, 77:471-480.